In the article titled “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab” [1], there were errors, which should be corrected as follows:(i)In Abstract, the term “(DEP)” should be “(PED).”(ii)In Results, “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 91 µm, NS; M12: 312 ± 84 µm, NS; M24: 312 ± 12.3, NS)” should be corrected to “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 14 µm, NS; M12: 313 ± 13.9 µm, NS; M24: 305 ± 76, NS).”(iii)In Table 2, there were errors in the values in the third, fourth, and sixth columns. The corrected table and its description are shown below.

Table 2 
Comparison of functional and morphologic changes from time of switch to 24 months.